NASDAQ
Altimmune, Inc. (ALT) has a price/sales ratio of 7757.46x as of Friday, May 22, 2026. This represents a 97.18% increase compared to its 12-month average of 3934.15x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.